52 products were found matching "K08529"!

A RARgamma agonist, selective for RARgamma over RARalpha and RARbeta in reporter assays using HeLa cells expressing chimeric RARgamma, RARalpha, or RARbeta receptors (EC50s = 7.7, 498, and 125 nM, respectively) and is inactive at the retinoid X receptor (RXR), reduces TPA-induced ear edema in a mouse model of...

Rabbit Polyclonal RARG Antibody against Human retinoic acid receptor gamma. Validated for Western Blot. Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative. Interspecies information: Highest antigen sequence indentity to the following orthologs: ENSMUSG00000001288: 79%,...

This nuclear receptor assay system utilizes proprietary non-human cells engineered to provide constitutive, high-level expression of the human retinoic acid receptor gamma (NR1B3), a ligand-dependent transcription factor commonly referred to as RARG or RARgamma. INDIGO's reporter cells include the luciferase...

The RAR gamma Reporter (Luc)-HEK293 cell line is designed for monitoring the activity of RARgamma. The RAR gamma Reporter (Luc)-HEK293 cell line contains a firefly luciferase gene under the control of retinoic acid response elements stably integrated into HEK293 cells along with full length human RARgamma (accession...

CD437 is the prototypical adamantyl arotinoid of the retinoid-related molecule family that acts as a selective agonist of retinoic acid receptor (RAR)gamma (Kds = 6.5 µM, 2.5 µM, and 77 nM for RARalpha, beta, and gamma, respectively). CD437 is cytotoxic to the acute myeloid leukemia cell line NB4 (EC50 = 0.17 µM),...

Fenretinide is a synthetic derivative of retinoic acid (Cay-11017) and an inhibitor of dihydroceramide desaturase (IC50 = 2.32 µM). It promotes the generation of reactive oxygen species (ROS), the degradation of anti-apoptotic MCL-1, and the cleavage of pro-apoptotic PKCdelta. At 5-20 µM, fenretinide selectively...

CD2665 is a selective retinoic acid receptor (RAR)beta and RARgamma antagonist (Kds = 110, 306, and > 2,250 nM for RARgamma, RARbeta, and RARalpha, respectively, with no binding at RXRalpha). At 10-7 M, it has been used to abrogate retinoic acid (Cay-11017)-induced antiproliferative and antidifferentiative effects...

Etretinate is a second-generation retinoid previously used systemically to manage psoriasis but withdrawn due to teratogenicity. Etretinate alters cAMP signaling, which may be defective in psoriasis.Formal Name: (2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid, ethyl ester....

CD1530 is a selective retinoic acid receptor (RARgamma) agonist (Kds = 150, 1,500, and 2,750 nM for RARgamma, RARbeta, and RARalpha receptors, respectively). It demonstrates transcriptional activity at RARgamma with an AC50 value of 1.8 nM. It has been used in combination with bexarotene (Cay-11571), a retinoid X...

MM-11253 is a synthetic, conformationally restricted retinoid that acts as a selective antagonist of retinoic acid receptor gamma (RARgamma). It dose-dependently blocks the ability of RARgamma-selective agonists, but not retinoic acid (all-trans retinoic acid, Cay-11017), to inhibit the growth of oral squamous cell...

A metabolite of etretinate. It is primarily used to treat skin disorders. It also appears to suppress the development of squamous cell carcinoma and chemically-induced epithelial tumors.

LY2955303 is a potent antagonist of retinoic acid receptor gamma (RARgamma, Ki = 1.1 nM). It is selective for RARgamma over RARalpha and RARbeta (Kis = >1,700 and >2,980 nM, respectively). LY2955303 reduces differential weight bearing between the contralateral and ipsilateral limbs in a rat model of...